Literature DB >> 15808003

Examples of doping control analysis by liquid chromatography-tandem mass spectrometry: ephedrines, beta-receptor blocking agents, diuretics, sympathomimetics, and cross-linked hemoglobins.

Mario Thevis1, Wilhelm Schänzer.   

Abstract

The application of modern and powerful analytical instruments consisting of liquid chromatographs (LCs), sophisticated atmospheric pressure ion sources, and sensitive mass analyzers has improved quality as well as speed of doping control analyses markedly during the last 5 years. Numerous compounds such as beta-receptor blocking agents or diuretics require derivatization prior to gas chromatographic (GC) and mass spectrometric (MS) measurement, which is the reason for extended sample preparation periods. In addition, several substances demonstrate poor GC-MS properties even after chemical modification, and peptide hormones such as cross-linked hemoglobins cannot be analyzed at all by means of GC-MS. With the availability of electrospray ionization and robust tandem MSs (e.g., triple-stage quadrupole or ion trap instruments) many new or complementary screening and confirmation assays have been developed, providing detailed qualitative and quantitative information on prohibited drugs. With selected categories of compounds (ephedrines, beta-blockers, b2-agonists, diuretics, and bovine hemoglobin-based oxygen therapeutics) that are banned according to the rules of the World Anti-Doping Agency and International Olympic Committee, the advantages of LC-MS-MS procedures over conventional GC-MS assays are demonstrated, such as enhanced separation of analytes, shorter sample pretreatment, and identification of substances that are not identified by GC-MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15808003     DOI: 10.1093/chromsci/43.1.22

Source DB:  PubMed          Journal:  J Chromatogr Sci        ISSN: 0021-9665            Impact factor:   1.618


  2 in total

1.  A simple and rapid ESI-LC-MS/MS method for simultaneous screening of doping agents in urine samples.

Authors:  I Madhusudhana Reddy; Alka Beotra; S Jain; S Ahi
Journal:  Indian J Pharmacol       Date:  2009-04       Impact factor: 1.200

2.  A Pharmacokinetic Study of Ephedrine and Pseudoephedrine after Oral Administration of Ojeok-San by Validated LC-MS/MS Method in Human Plasma.

Authors:  Sooyoung Lee; Wang-Seob Shim; Heejo Yoo; Sanghee Choi; Jiyoung Yoon; Kwang-Young Lee; Eun-Kyoung Chung; Byung-Cheol Lee; Sung-Vin Yim; Bo-Hyung Kim; Kyung-Tae Lee
Journal:  Molecules       Date:  2021-11-19       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.